| Literature DB >> 32733213 |
June van Aalst1, Jenny Ceccarini1, Koen Demyttenaere2,3, Stefan Sunaert4,5, Koen Van Laere1,6.
Abstract
Yoga is becoming increasingly popular worldwide, with several implicated physical and mental benefits. Here we provide a comprehensive and critical review of the research generated from the existing neuroimaging literature in studies of yoga practitioners. We reviewed 34 international peer-reviewed neuroimaging studies of yoga using magnetic resonance imaging (MRI), positron emission tomography (PET), or single-photon emission computed tomography (SPECT): 11 morphological and 26 functional studies, including three studies that were classified as both morphological and functional. Consistent findings include increased gray matter volume in the insula and hippocampus, increased activation of prefrontal cortical regions, and functional connectivity changes mainly within the default mode network. There is quite some variability in the neuroimaging findings that partially reflects different yoga styles and approaches, as well as sample size limitations. Direct comparator groups such as physical activity are scarcely used so far. Finally, hypotheses on the underlying neurobiology derived from the imaging findings are discussed in the light of the potential beneficial effects of yoga.Entities:
Keywords: MRI; PET; SPECT; connectivity; neurobiology; neuroimaging; yoga
Year: 2020 PMID: 32733213 PMCID: PMC7362763 DOI: 10.3389/fnint.2020.00034
Source DB: PubMed Journal: Front Integr Neurosci ISSN: 1662-5145
Morphological brain imaging studies on yoga.
| Imaging technique | Effect | Design | Yoga style | Number (♀), age (mean ± SD), yrs | Control group Control condition | Study |
| MRI-VBM | WB GMD | CSS | Hatha Yoga meditation (HYM) (MY) | HYM: 7 (6), 36.4 ± 11.9 CON: 7 (6), 35.5 ± 7.1 | Non-meditators vs. yoga | |
| MRI-VBM MRI-VBCT MRI-DTI | WB GMD, GMT, ROI WM | CSS | Unspecified yoga (3Y) | YOG: 14 (9), 37.0 ± 6.6 CON: 14 (9), 36.7 ± 7.3 | Non-meditators vs. yoga | |
| MRI-VBM | WB GMD | CSS | Unspecified yoga (3Y) | YOG: 14 (9) 37.0 ± 6.6 CON: 14 (9) 36.7 ± 7.3 | Non-meditators vs. yoga | |
| MRI-VBM | WB GMD | CSS | Sahaja Yoga meditation (SYM)(YM) | SYM: 23 (17), 46.5 ± 11.4 CON: 23 (17), 46.9 ± 10.9 | Non-meditators vs. yoga | |
| MRI-VBM | WB GMD | LS | Sahaja yoga meditation (SYM)(MY) | SYM: 12 (2): 21.6 ± 2.0 CON: 30 (12): 22.2 ± 1.3 | SYM training vs. control group (waiting period) | |
| MRI-VBCT | WB GMT | CSS | Hatha Yoga (3Y) | YOG: 21 (21), 66.2 ± 4.5 CON: 21 (21), 67.9 ± 4.6 | Non-meditators vs. yoga | |
| MRI-VBM | ROI GMV | CSS LS | Meditation and yoga practices (MY/3Y) | YOG: 289 (211), 61.9 ± 6.8 CON: 3453 (1830), 64.3 ± 7.7 | Controls vs. practitioners of yoga, meditation and breathing exercises | |
| MRI-VBM | ROI GMD | LS | Yoga (3Y) | YOG: 7 (3), 69–81* | Before vs. after yoga training | |
| MRI-VBM | ROI GMD | CSS | Hatha, iyengar and kundalini yoga (3Y) | YOG: 13 (12), 35.8 ± 15.4 CON: 13 (12), 35.7 ± 14.6 | Controls vs. yoga practitioners | |
| MRI-VBM | ROI GMD | LS | MBSR program (including yoga) (MY/3Y) | YOG: 27 (16), 35.2 ± 6.7 | Before vs. after MBSR training | |
| MRI-VBM | ROI GMV | LS | Combination of meditation and Kundalini yoga (MY/3Y) | YOG: 14 (6), 67.1 ± 9.5 CON: 11 (6), 67.8 ± 9.7 | MET vs. yoga in MCI patients |
Functional brain imaging studies on yoga.
| Imaging technique | Effect | Design | Yoga style | Number (♀), age (mean ± SD), yrs | Control group Control condition | Study |
| 18F-FDG PET | Glucose metabolism | CSS | Yoga meditation (YM) | YOG: 8 (2), 32, 21–39* | Wakeful condition in the same subjects | |
| H215O PET | CBF | CSS | Yoga Nidra (YM) | YOG: 9 (3), 23–41* | Control states in the same subjects | |
| 99mTc-ECD SPECT | CBF | LS | Iyengar yoga (3Y) | YOG: 4 (2), 45.0 | Pre-program baseline scan | |
| 99mTc-HMPAO SPECT | CBF | CSS | Kundalini chanting (YM) | YOG: 11 (5), 35.4 ± 13.5 | BL in same subjects | |
| fMRI ASL | CBF | CSS | Kundalini meditation (YM) | YOG: 10 (4), 53.7* | BL in same subjects | |
| fMRI | Neural activation | CSS | Kundalini, Acem tradition (MY) | YOG: 8 (5), 34.6 ± 9.7 | BL in same subjects | |
| fMRI | Neural activation | CSS | OM chanting (MY) | YOG: 12 (3), 28 ± 6 | Production of “ssss…” | |
| fMRI | Neural activation | CSS | Sahaja yoga meditation (MY) | YOG: 19 (11), 46.6 ± 9.5 | Attention on breathing | |
| fMRI | Neural activation | CSS | YOG: 4 (0), mid 60s* | Relaxation (control condition) vs. meditation | ||
| fMRI | Neuronal fluctuations | LS | Hatha Yoga (3Y) | CON: 12 (12), 16–60* YOG: 23 (23), 16–60* AE: 23 (23), 16–60* | Patients with schizophrenia: control wait-list vs. yoga vs. aerobic exercises (AE) | |
| fMRI | Neural activation | CSS | Undefined | YOG: 19 (16), 35.9 ± 11.5 CON: 12 (6), 32.9 ± 9.1 | Recreational athletes vs. yoga practitioners (YP) | |
| fMRI | Neural activation | CSS | Hatha meditation (MY) | YOG: 7 (6), 36.4 ± 11.9 CON: 7 (6), 35.5 ± 7.1 | Meditation-naive vs. controls | |
| fMRI | Neural activation | CSS | Hatha, iyengar, and kundalini (MY/3Y) | YOG: 13 (12), 35.8 ± 15.4 CON: 13 (12), 35.7 ± 14.6 | Controls vs. yoga practitioners | |
| fMRI | Functional connectivity | CSS | Hatha meditation (MY) | YOG: 7 (6), 36.4 ± 11.9 CON: 7 (6), 35.5 ± 7.1 | Meditation-naive vs. controls | |
| fMRI | Functional connectivity | CSS | Sahaja yoga meditation (SYM)(YM) | SYM: 23 (17), 46.5 ± 11.4 CON: 23 (17), 46.9 ± 10.9 | Meditation state vs. resting state | |
| fMRI | Functional connectivity | LS | MBSR program (including yoga) (MY/3Y) | MBSR: 18 (10): 37.5 ± 9.1 RR: 16 (9): 39.9 ± 10.3 | MBSR vs. relaxation response RR training | |
| fMRI | Functional connectivity | CSS | Hatha yoga (3Y) | CON: 20 (20), 68.2 ± 4.6 YOG: 20 (20), 66.5 ± 4.5 | Elderly yoga practitioners vs. healthy yoga-naïve controls | |
| fMRI | Functional connectivity | LS | Meditation/Kundalini yoga (MY/3Y) | YOG: 14 (6), 67.1 ± 9.5 MET: 11 (6), 67.8 ± 9.7 | MET vs. yoga in MCI patients | |
| fMRI | Functional connectivity | LS | Sahaja yoga meditation (SYM)(MY) | SYM: 12 (2): 21.6 ± 2.0 CON: 30 (12): 22.2 ± 1.3 | SYM training vs. control group (waiting period) | |
| fMRI | Functional connectivity | CSS | Kripalu yoga, Vipassana meditation (MY/3Y) | YOG: 16 (11), 49.4 ± 7.8 MED: 16 (10), 54.1 ± 8.1 CON: 15 (9), 52.9 ± 9.8 | Meditation vs. yoga vs. controls | |
| 11C-raclopride PET | Dopamine release | CSS | Yoga Nidra (MY) | YOG: 8 (0), 31–50* | Wakeful condition in same subjects | |
| MRI-MRS | GABA | CSS | Yoga (3Y) | YOG: 8 (7), 25.8 ± 5.2 CON: 11 (5), 26.6 ± 7.6 | Reading exercise | |
| MRI-MRS | GABA | LS | Iyengar yoga (3Y) | YOG: 19 (11), 23.9 ± 3.0 CON: 15 (11) 25.6 ± 4.9 | Walking group | |
| MRI-MRS | NAA and MI | CSS | Yoga postures and breathing exercises (3Y) | YOG: 34 (?), 35–65* CON: 34 (?), 35–65* | Type 2 diabetes patients: Yoga + standard care vs. standard care | |
| MRI-MRS | NAA and MI | CSS | Yoga postures and breathing exercises (3Y) | YOG: 5 (?), 35–55* CON: 5 (?), 35–55* | Type 2 diabetes patients: Yoga + standard care vs. standard care | |
| MRI-MRS | Metabolites | LS | Meditation/Kundalini yoga (MY/3Y) | YOG: 14 (6), 67.1 ± 9.5 CON: 11 (6), 67.8 ± 9.7 | MET vs. yoga in MCI patients | |
FIGURE 1An overview of morphological and functional effects of yoga, overlaid on a T1-weighted image. (A) Morphological effects: circles indicate regions with increased gray matter volume or density; regions with a decrease are represented by an arrow pointing down. Both whole-brain and ROI analyses are included, represented by circles without or with a white border, respectively. Size of the circles are a representation of group sizes: light blue (Hernández et al., 2016), dark blue (Froeliger et al., 2012b), orange (Villemure et al., 2014), red (Villemure et al., 2015), yellow (Dodich et al., 2019), dark yellow (Afonso et al., 2017), pink (Gotink et al., 2018), dark green (Gothe et al., 2018), light green (Hariprasad et al., 2013), purple (Hölzel et al., 2009), not in this figure (Yang et al., 2016). (B) Neuronal resting-state function: red (Herzog et al., 1991), blue (Khalsa et al., 2009), not in this figure (Lou et al., 1999; Cohen et al., 2009; Wang et al., 2011). (C) Neural activation: red (Engström et al., 2010), purple (Kalyani et al., 2011), green (Froeliger et al., 2012c), pink (Hernández et al., 2015), orange (Mishra et al., 2017), yellow (Wadden et al., 2018), dark blue (Gothe et al., 2018), and light blue (Lin et al., 2015). (D) Functional connectivity, seed regions (circles with a white border) connected (full lines) with brain regions (circles), representing higher functional connectivity: red (Gard et al., 2015); higher degree centrality for caudate nuclei, blue (Hernández et al., 2018), green (Sevinc et al., 2018), pink (Eyre et al., 2016), purple (Santaella et al., 2019), light blue represents a network with a change in power spectrum (Dodich et al., 2019), not in this figure (Froeliger et al., 2012a). (E) Neurotransmitters and metabolites: yellow, increased dopamine signaling (Kjaer et al., 2002); red, increased GABA without exact location (Streeter et al., 2007); dark blue (GABA levels) (Streeter et al., 2010); green, increased N-acetyl-aspartate (NAA) and decrease myoinositol (MI) (Nagothu et al., 2015); purple, no change in MI or NAA (Santhakumari et al., 2016); white, no change in metabolite levels in hippocampus and dorsal anterior cingulate cortex (Yang et al., 2016).